Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Germing

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Der Internist|December 22, 1998
[Vaccination after splenectomy and in asplenia]U Germing
Leukemia|May 16, 2008
The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic featuresA Orazi, U Germing
Der Radiologe|August 10, 2000
[Aspects of internal medicine]R Haas, U Germing
Leukemia Research|October 31, 2001
Refractory anemia with excess of blasts in transformation: a dying category?U Germing, N Gattermann
Leukemia|May 7, 2013
Combination of azacitidine and lenalidomide in myelodysplastic syndromes or acute myeloid leukemia-a wise liaison?U Platzbecker, U Germing
Der Internist|December 22, 1998
[Myelodysplastic syndromes]C Aul, U Germing
Der Internist|January 19, 2010
[Myelodysplastic syndromes]C Aul, A Giagounidis, U Germing
European Journal of Haematology|January 1, 1998
Improved prophylaxis against overwhelming postsplenectomy infectionsU Germing, A Gaigounidis, W Schneider
International Journal of Oncology|May 10, 2011
Expression of cd34 and p-glycoprotein - prognostic-significance in primary myelodysplastic syndromesV Runde, U Germing, C Aul
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Prevention of postsplenectomy sepsisU Germing, A Giagounidis, C Strupp
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Der Internist|December 22, 1998
[Vaccination after splenectomy and in asplenia]U Germing
Leukemia|May 16, 2008
The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic featuresA Orazi, U Germing
Der Radiologe|August 10, 2000
[Aspects of internal medicine]R Haas, U Germing
Leukemia Research|October 31, 2001
Refractory anemia with excess of blasts in transformation: a dying category?U Germing, N Gattermann
Leukemia|May 7, 2013
Combination of azacitidine and lenalidomide in myelodysplastic syndromes or acute myeloid leukemia-a wise liaison?U Platzbecker, U Germing
Der Internist|December 22, 1998
[Myelodysplastic syndromes]C Aul, U Germing
Der Internist|January 19, 2010
[Myelodysplastic syndromes]C Aul, A Giagounidis, U Germing
European Journal of Haematology|January 1, 1998
Improved prophylaxis against overwhelming postsplenectomy infectionsU Germing, A Gaigounidis, W Schneider
International Journal of Oncology|May 10, 2011
Expression of cd34 and p-glycoprotein - prognostic-significance in primary myelodysplastic syndromesV Runde, U Germing, C Aul
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Prevention of postsplenectomy sepsisU Germing, A Giagounidis, C Strupp
Pageof 13